
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1012 | 1000 | 1064 | 1286 | 1634 | 2546 |
Fund Return | 1.2% | 0.03% | 6.43% | 8.76% | 10.32% | 9.8% |
Place in category | 1605 | 1618 | 1761 | 1139 | 887 | 124 |
% in Category | 85 | 85 | 97 | 75 | 69 | 22 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Eq Cl Sr Adv | 7.26B | 1.00 | 7.44 | 8.45 | ||
Manulife Glbl Eq Cl Sr FT6 | 7.26B | 1.20 | 8.77 | 9.80 | ||
Manulife Glbl Eq Cl Sr T6 | 7.26B | 1.00 | 7.43 | 8.44 | ||
Manulife Div incm Fd Sr Adv | 6.58B | 1.45 | 6.72 | 8.42 | ||
Manulife Div incm Fd Sr F | 6.58B | 1.64 | 7.92 | 9.64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 17.07B | -0.93 | 23.49 | - | ||
Capital Group Glbal Equity Fd F CAD | 13.19B | 2.07 | 11.83 | 10.97 | ||
Capital Group Glbal Equity Fd A CAD | 13.19B | 1.89 | 10.61 | 9.74 | ||
Capital Group Glbal Equity Fd D CAD | 13.19B | 2.03 | 11.47 | 10.50 | ||
EdgePoint Global Portfolio Series A | 12.53B | 5.91 | 8.67 | 7.60 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.19 | 86.78 | +0.05% | |
Marsh McLennan | US5717481023 | 4.43 | 243.16 | -0.36% | |
Alphabet C | US02079K1079 | 4.14 | 158.12 | +1.21% | |
Microsoft | US5949181045 | 4.14 | 380.41 | +1.34% | |
UnitedHealth | US91324P1021 | 3.93 | 522.14 | -0.31% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review